TABLT Online Pharmacy Company raises $1.5 mn in pre-Series A round

Published On 2022-03-01 08:59 GMT   |   Update On 2022-03-01 08:59 GMT

New Delhi : TABLT Pharmacy, an Indian Online Pharmacy Company announced that it has raised $1.5 million in pre-series A funding round. Launched in 2018, Tablt pharmacy deals in medicines, OTCs, and other healthcare products.The company serves customers across cities like Arambagh, Ghatal, Asansol, Durgapur, Burdwan, Bankura Town, Dhanbad, Siliguri, Patna, Bagnan and many more in states of...

Login or Register to read the full article

New Delhi : TABLT Pharmacy, an Indian Online Pharmacy Company announced that it has raised $1.5 million in pre-series A funding round. Launched in 2018, Tablt pharmacy deals in medicines, OTCs, and other healthcare products.

The company serves customers across cities like Arambagh, Ghatal, Asansol, Durgapur, Burdwan, Bankura Town, Dhanbad, Siliguri, Patna, Bagnan and many more in states of West Bengal, Bihar, Jharkhand & Orissa .

Founded by Anish Agarwal and Anant Jain the pharmacy has successfully raised $1.5 million from an impressive line–up of investors in pre-series A-round like JITO Angel Network, Tech Innovation (Chennai based), Let's Venture, Seeders Syndicate (Kolkata based), Angel Bay and other angel investors. Also, the founders have themselves participated in this round, the statement said.

Speaking on the funding, Sunil Singhvi, Vice Chairman, JITO says, "Tablt is a Bharat-focused Online pharmacy, guaranteeing 24-hour delivery in the remotest part of Bharat, where more than 65% of India resides. Presently serving 4 states, Tablt aspires to be in 10+states in the next two years. We at JITO Angel Network, believe that Tablt will capture a major share in the coming years. We have backed Tablt since their inception and have confidence that Tablt will be a market leader in the Bharat market."
Abhishek Rungta, Partner, Seeders says, "We are very upbeat about the opportunity Bharat presents for an efficient consumer Internet business like Tablt. They are solving a real problem effectively, and we are excited to be part of this journey."

Mahesh Ramachandran, CEO, Tech Innovation, adds, "We have a strategic thesis with a focus on Bharat in addition to our interest in emerging technology at Tech Innovations. Tablt fits in perfectly with this vision and we plan to expand together. Their Healthtech solution along with our existing phygital platform of financial services across India, we are leveraging both – our distribution network across 20+ states and 30,000 locations."

Speaking on the pre-A series fundraising, founder Anish Agarwal says, "We are very excited about raising a pre-A series round of funding. I would like to add here that the company has achieved six-fold growth since April 2020. Now, we are geared up for four times growth in the next 15 months."

Buoyed by this successful round of funding, the company's future plans entail opening 500 new franchisees thus creating a network of more than 1000 franchisees in the current year – 2022, a statement added.

Funds will be deployed to build teams across Tech, Product & Marketing functions. Besides, it has plans to open 'Fulfilment Centres' in Bhubaneswar, Patna and Siliguri.TABLT Pharmacy is aiming to tie up with strategic partners in the healthcare ecosystem.

Read Also - Mankind Pharma to acquire Panacea Biotech's domestic brands for India and Nepal for Rs.1,872 crore




Tags:    
Article Source : With Inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News